Asperger's Syndrome
14
2
3
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
7.1%
1 terminated out of 14 trials
90.9%
+4.4% vs benchmark
7%
1 trials in Phase 3/4
60%
6 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (14)
Recovery in Telling Life Stories
Genetic Contributions to Autism Spectrum Disorders
Psychotherapy for Anxiety in Children With Autism Spectrum Disorder
Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
A Folinic Acid Intervention for Autism Spectrum Disorders
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism
My Scrivener® - Measuring Effectiveness and Dose Response in Children